{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:03:47Z","timestamp":1783065827450,"version":"3.54.6"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Keloids represent a troublesome condition that lacks a proper standard management protocol. Insulin and botulinum toxin A (BTX-A) both have evidence-based anti-scarring effects. Hence, their role in treating keloids needs to be investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To compare insulin's efficacy versus BTX-A in treating keloids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS AND METHODS<\/jats:title>\n            <jats:p>Sixty-three patients with keloids were randomly allocated into 3 equal groups. Group A was treated with intralesional insulin, Group B with intralesional BTX-A, and Group C with intralesional corticosteroids, each for 4 monthly sessions. The results were assessed objectively and subjectively using the patient and observer scar assessment scale.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>All 3 groups showed a statistically significant reduction in volume before and after therapy, with percent changes of 66.6%, 25.3%, and 75% for Groups A, B, and C, respectively. Insulin and corticosteroids were statistically superior to BTX-A in improving pigmentation, reducing thickness, and inducing relief in treated keloids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Both insulin and BTX-A show a promising role in managing keloids, with insulin demonstrating better efficacy. Botulinum toxin A is better recommended as an adjuvant therapy alongside other mainstay treatment modalities. Larger-scale studies are needed to confirm their roles and establish guidelines for their use.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004566","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:58:24Z","timestamp":1741103904000},"page":"593-598","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Intralesional Insulin Is Superior to Intralesional Botulinum Toxin-A in the Treatment of Keloids"],"prefix":"10.1097","volume":"51","author":[{"given":"Mona","family":"Elradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina E.","family":"Hamed","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of Dermatology, Venereology and Andrology, Zagazig University Hospitals, Zagazig, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"R1-20250529","first-page":"33","article-title":"Keloids: a review of etiology, prevention and treatment","volume":"13","author":"Betarbet","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"R2-20250529","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1242\/jcs.107.5.1137","article-title":"Neutralising antibody to TGF-\u03b21,2 reduces cutaneous scarring in adult rodents","volume":"107","author":"Shah","year":"1994","journal-title":"J Cell Sci"},{"key":"R3-20250529","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijsu.2006.04.007","article-title":"Transforming growth factor beta (TGFbeta) and keloid disease","volume":"5","author":"Jagadeesan","year":"2007","journal-title":"Int J Surg"},{"key":"R4-20250529","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-4632.2009.04143.x","article-title":"Role of vascular endothelial growth factor in keloids: a clinicopathologic study","volume":"48","author":"Salem","year":"2009","journal-title":"Int J Dermatol"},{"key":"R5-20250529","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2133.2003.05174.x","article-title":"Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and\/or prevention of keloids","volume":"148","author":"Phan","year":"2003","journal-title":"Br J Dermatol"},{"key":"R6-20250529","first-page":"455","article-title":"The use of insulin in open-wound healing","volume":"65","author":"Belfield","year":"1970","journal-title":"Vet Med Small Anim Clin"},{"key":"R7-20250529","doi-asserted-by":"crossref","first-page":"476e","DOI":"10.1097\/PRS.0000000000004199","article-title":"Low-dose insulin as an antiscarring therapy in breast surgery: a randomized controlled trial","volume":"141","author":"Hallam","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R8-20250529","first-page":"184","article-title":"Difficult to heal wounds intralesional insulin therapy trial","volume":"8","author":"Kalil Gaspar","year":"2020","journal-title":"J Surg"},{"key":"R9-20250529","first-page":"000173","article-title":"Role of insulin in prevention of hypertrophic scars","volume":"5","author":"Reddy","year":"2020","journal-title":"Adv Pharmacol Clin Trials"},{"key":"R10-20250529","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jaad.2020.05.152","article-title":"Microneedling with autologous platelet-rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: a simultaneous split-face comparative study","volume":"84","author":"Pawar","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R11-20250529","first-page":"bio026187","article-title":"Insulin regulates multiple signaling pathways leading to monocyte\/macrophage chemotaxis into the wound tissue","volume":"7","author":"Liu","year":"2018","journal-title":"Biol Open"},{"key":"R12-20250529","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/ced.12407","article-title":"Expression of insulin\u2010like growth factor\u20101 receptor in keloid and hypertrophic scar","volume":"39","author":"Hu","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"R13-20250529","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jocd.12134","article-title":"Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial","volume":"14","author":"Shaarawy","year":"2015","journal-title":"J Cosmet Dermatol"},{"key":"R14-20250529","doi-asserted-by":"crossref","first-page":"e15748","DOI":"10.1111\/dth.15748","article-title":"Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: clinical and pathological study","volume":"35","author":"Khatery","year":"2022","journal-title":"Dermatol Ther"},{"key":"R15-20250529","doi-asserted-by":"crossref","first-page":"2059513120926628","DOI":"10.1177\/2059513120926628","article-title":"The use of botulinum toxin in keloid scar management: a literature review","volume":"6","author":"Sohrabi","year":"2020","journal-title":"Scars Burns Heal"},{"key":"R16-20250529","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11136-022-03244-6","article-title":"Development of the patient scale of the patient and observer scar assessment scale (POSAS) 3.0: a qualitative study","volume":"32","author":"Carri\u00e8re","year":"2023","journal-title":"Qual Life Res"},{"key":"R17-20250529","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000529220","article-title":"Intralesional corticosteroid administration in the treatment of keloids: a scoping review on injection methods","volume":"239","author":"Yin","year":"2023","journal-title":"Dermatology"},{"key":"R18-20250529","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1042\/BST0370882","article-title":"IGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response","volume":"37","author":"Sureshbabu","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"R19-20250529","first-page":"25","article-title":"Reduction of ischemic damage by application of insulin-like growth factor-1 in rat brain after transient ischemia","volume":"55","author":"Wang","year":"2001","journal-title":"Acta Med Okayama"},{"key":"R20-20250529","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3892\/br.2021.1442","article-title":"Insulin-like growth factor-I and wound healing, a potential answer to non-healing wounds: a systematic review of the literature and future perspectives","volume":"15","author":"Garoufalia","year":"2021","journal-title":"Biomed Rep"},{"key":"R21-20250529","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(68)91898-9","article-title":"Local insulin for diabetic gangrene","volume":"1","author":"Lopez","year":"1968","journal-title":"Lancet"},{"key":"R22-20250529","first-page":"451","article-title":"Evaluation of the effects of topical insulin on wound-healing in the distal limb of the horse","volume":"71","author":"Edmonds","year":"1976","journal-title":"Vet Med Small Anim Clin"},{"key":"R23-20250529","first-page":"298","article-title":"The effect of topical insulin on infected cutaneous ulcerations in diabetic and nondiabetic mice","volume":"22","author":"Hanam","year":"1983","journal-title":"J Foot Surg"},{"key":"R24-20250529","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005373-199802000-00019","article-title":"Effects of insulin on wound healing","volume":"44","author":"Pierre","year":"1998","journal-title":"J Trauma"},{"key":"R25-20250529","first-page":"22","article-title":"A randomized, double-blind, placebo-controlled trial to determine the effects of topical insulin on wound healing","volume":"55","author":"Rezvani","year":"2009","journal-title":"Ostomy Wound Manage"},{"key":"R26-20250529","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1097\/00006534-200005000-00005","article-title":"Treatment of facial wounds with botulinum toxin a improves cosmetic outcome in primates","volume":"105","author":"Gassner","year":"2000","journal-title":"Plast Reconstr Surg"},{"key":"R27-20250529","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00266-009-9423-z","article-title":"Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report","volume":"34","author":"Xiao","year":"2010","journal-title":"Aesthet Plast Surg"},{"key":"R28-20250529","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/molecules17022169","article-title":"Effects of botulinum toxin type A on collagen deposition in hypertrophic scars","volume":"17","author":"Xiao","year":"2012","journal-title":"Molecules"},{"key":"R29-20250529","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","article-title":"Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthet Plast Surg"},{"key":"R30-20250529","doi-asserted-by":"crossref","first-page":"275e","DOI":"10.1097\/PRS.0b013e3181b98ee7","article-title":"Intralesional botulinum toxin type A injection as a new treatment measure for keloids","volume":"124","author":"Zhibo","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R31-20250529","first-page":"306","article-title":"Botulinum toxin type A effects on the treatment of keloid lesions: comparison of intralesional two different doses","volume":"3","author":"Fathi","year":"2017","journal-title":"Int J Med Res Prof"},{"key":"R32-20250529","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/09546634.2019.1628171","article-title":"Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions","volume":"31","author":"Gamil","year":"2020","journal-title":"J Dermatol Treat"},{"key":"R33-20250529","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000342125","article-title":"Botulinum toxin A for the treatment of keloids","volume":"25","author":"Gauglitz","year":"2012","journal-title":"Skin Pharmacol Physiol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:00:15Z","timestamp":1748538015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004566","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}